Capital Planning Advisors, LLC Bristol Myers Squibb CO Transaction History

Capital Planning Advisors, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 14, 2019	SELL	$45.12 - $53.8 $283,895 - $338,509	-6,292 Closed	0 $0
Q4 2018 Feb 13, 2019	SELL	$48.76 - $63.23 $644,948 - $836,343	-13,227 Reduced 67.76%	6,292 $327,000
Q3 2018 Nov 14, 2018	BUY	$55.19 - $62.25 $231,080 - $260,640	4,187 Added 27.31%	19,519 $1.21 Million
Q2 2018 Aug 08, 2018	SELL	$50.53 - $62.98 $713,382 - $889,151	-14,118 Reduced 47.94%	15,332 $848,000
Q1 2018 May 15, 2018	SELL	$59.92 - $68.98 $354,486 - $408,085	-5,916 Reduced 16.73%	29,450 $1.86 Million
Q4 2017 Feb 08, 2018	SELL	$59.94 - $65.35 $263,436 - $287,213	-4,395 Reduced 11.05%	35,366 $2.17 Million
Q3 2017 Nov 09, 2017	BUY	$55.23 - $63.74 $2.2 Million - $2.53 Million	39,761	39,761 $2.53 Million

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Capital Planning Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Capital Planning Advisors, LLC with notifications on news.